Makishima, H <br/><br/>
CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.  [electronic resource] 

 -  Leukemia  Jul 2012 
 - 1547-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2012.7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blotting, Western<br/>Cell Proliferation--drug effects<br/>Flow Cytometry<br/>Granulocyte-Macrophage Colony-Stimulating Factor--metabolism<br/>Humans<br/>Immunoenzyme Techniques<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mutation--genetics<br/>Phosphorylation--drug effects<br/>Prognosis<br/>Protein Binding<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-cbl--genetics<br/>Proto-Oncogene Proteins c-kit--genetics<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Tumor Cells, Cultured<br/>src-Family Kinases--antagonists & inhibitors